What is Winstrol?
Winstrol (Stanozolol) is an oral, 17a-alkylated DHT derivative - one of the best-known cutting steroids. It does not aromatize and gives muscle a very dry, hard look at low body fat. It also lowers SHBG, freeing up more available testosterone. Clinically stanozolol is still used for hereditary angioedema.
This information is for research and educational purposes only. No medical advice.
Comparison
One compound, three forms
Stanozolol and a related oral DHT derivative in the TPD lexicon, as described there. Tap a card to open its entry.
Simplified: all act on the androgen receptor. The form sets how the compound reaches the blood. 8
How it works
As a DHT derivative stanozolol does not aromatize - no estrogen water retention, hence the "dry" effect. It also lowers SHBG markedly, raising the fraction of free, active testosterone. The look is hard and defined but only visible at already low body fat.
Where it acts
Where stanozolol acted in studies
Tap a point or a card. Colour = androgen receptor, grey = observed in studies.
- Muscle and weight
Weight gain similar to testosterone3
AR - Liver
Hepatic lipase 123 percent higher, liver values temporarily raised in some3
Observed in trials - Blood lipids
HDL down to -53 percent, LDL to HDL ratio from 2.5 to 6.84
Observed in trials - Hormone axis
Suppressed the body's own hormones less than testosterone3
Observed in trials - Skin and hair
Acne and increased hair growth in the long-term study1
Observed in trials
Targets in the ChEMBL database8
Compound CHEMBL2079587: one recorded mechanism, agonist with direct binding to the human receptor.
- Gene
- AR
- UniProt
- P10275
- ChEMBL
- CHEMBL1871
- Action
- Agonist, direct binding
Use and dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
What the research shows
Stanozolol has a real clinical data base: it has been used for decades as prophylaxis in hereditary angioedema, with long-term safety studied (Sloane et al., J Allergy Clin Immunol 2007). The AAS pharmacology is summarized in Kicman (2008).
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Blood lipids after 6 weeks3
Change in percent, 11 weight lifters, stanozolol and testosterone one after the other (crossover)
Stanozolol as a tablet, testosterone as an injection into the muscle. Hepatic lipase rose by 123 percent on stanozolol. Both groups gained weight similarly.
Blood lipids after 6 weeks4
Change in percent, 10 postmenopausal women with osteoporosis
Total cholesterol and triglycerides stayed the same, the LDL to HDL ratio rose from 2.5 to 6.8. All changes had reversed 5 weeks after stopping.
Research status
Where the research stands
ClinicalTrials.gov knows only one trial with stanozolol tablets, together with another agent in a blood disorder. Its status is unknown, it had last not yet started. It is not listed here. As of 26 Oct 2026. 7
- Preclinical Blood lipids and vessels in an animal model (rabbits)
- Phase 1 no registered trial
- Phase 2 no registered trial
- Phase 3 no registered trial
- Approval from 1962, no longer marketed today
The approval predates today's trial registries, so the register shows no current trial for this form. 7
Side effects
- Liver: 17a-alkylated, markedly liver-loading - limit cycle, liver support.
- Joints: the "dry" effect can make joints dry and painful.
- Lipids: lowers HDL strongly - one of the harshest steroids on cholesterol.
- Androgenic (DHT derivative) - hair loss in predisposed individuals, acne.
- HPTA suppression - PCT topic.
Tolerability
Frequency in two studies
Out of 100 participants, how many had the event. Two small studies with 21 people each, both with low-dose tablets.
In the long-term study: increased hair growth, weight gain, menstrual changes, acne and mood changes, all receding with a lower dose. Five people had low HDL, two raised triglycerides, liver values showed no lasting abnormality. In the 6-month study liver values rose temporarily in some.51
Storage
Store dry and cool, protected from light. Out of reach of children.